• 2003

Company Description

Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.

Etubics Corporation is a Seattle based biopharmaceutical company developing targeted immunotherapies and vaccine products for a wide range of resilient diseases. Etubics patent-protected technology has been proven to be safer, more efficient and more effective than current vectored vaccines and gene delivery platforms.